Nuveen Asset Management LLC reduced its holdings in Anthem, Inc. (NYSE:ANTM – Get Rating) by 5.3% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 2,348,630 shares of the company’s stock after selling 132,059 shares during the period. Nuveen Asset Management LLC’s holdings in Anthem were worth $1,088,683,000 as of its most recent filing with the Securities & Exchange Commission.
Several other large investors have also modified their holdings of ANTM. Industrial Alliance Investment Management Inc. purchased a new position in shares of Anthem during the 4th quarter worth about $26,000. Trust Co. of Vermont bought a new stake in Anthem during the 4th quarter valued at about $31,000. Bell Investment Advisors Inc bought a new stake in shares of Anthem in the 3rd quarter valued at about $37,000. Fieldpoint Private Securities LLC raised its holdings in shares of Anthem by 57.8% in the 3rd quarter. Fieldpoint Private Securities LLC now owns 101 shares of the company’s stock valued at $38,000 after purchasing an additional 37 shares in the last quarter. Finally, Benjamin Edwards Inc. raised its holdings in shares of Anthem by 145.9% in the 4th quarter. Benjamin Edwards Inc. now owns 91 shares of the company’s stock valued at $42,000 after purchasing an additional 54 shares in the last quarter. 84.28% of the stock is owned by institutional investors and hedge funds.
NYSE ANTM traded up $7.65 during trading on Thursday, reaching $512.43. 987,931 shares of the company’s stock were exchanged, compared to its average volume of 1,193,833. The stock has a market cap of $123.54 billion, a P/E ratio of 20.17, a price-to-earnings-growth ratio of 1.35 and a beta of 0.97. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.36 and a current ratio of 1.36. The company has a 50 day moving average price of $498.07 and a two-hundred day moving average price of $462.51. Anthem, Inc. has a 1 year low of $355.43 and a 1 year high of $533.68.
The company also recently announced a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 10th will be issued a $1.28 dividend. This is an increase from Anthem’s previous quarterly dividend of $1.13. This represents a $5.12 annualized dividend and a dividend yield of 1.00%. The ex-dividend date is Thursday, June 9th. Anthem’s payout ratio is presently 20.16%.
In other Anthem news, Director Ramiro G. Peru sold 990 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $468.88, for a total transaction of $464,191.20. Following the completion of the sale, the director now directly owns 9,405 shares of the company’s stock, valued at approximately $4,409,816.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CAO Ronald W. Penczek sold 2,423 shares of the company’s stock in a transaction that occurred on Thursday, March 3rd. The shares were sold at an average price of $463.68, for a total value of $1,123,496.64. The disclosure for this sale can be found here. Insiders sold a total of 21,116 shares of company stock valued at $9,743,637 over the last three months. Company insiders own 0.28% of the company’s stock.
A number of research analysts have recently issued reports on the stock. SVB Leerink lifted their price objective on shares of Anthem from $483.00 to $555.00 and gave the stock a “market perform” rating in a research report on Thursday, April 21st. The Goldman Sachs Group boosted their target price on shares of Anthem from $527.00 to $605.00 and gave the stock a “buy” rating in a research report on Thursday, April 21st. Argus boosted their target price on shares of Anthem from $475.00 to $500.00 and gave the stock a “buy” rating in a research report on Monday, February 7th. UBS Group boosted their target price on shares of Anthem from $477.00 to $541.00 and gave the stock a “buy” rating in a research report on Tuesday, March 29th. Finally, Cowen boosted their target price on shares of Anthem from $472.00 to $642.00 in a research report on Thursday, April 21st. Two investment analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Buy” and an average price target of $544.95.
Anthem Company Profile (Get Rating)
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
- Get a free copy of the StockNews.com research report on Anthem (ANTM)
- Genesco Pops On Earnings But Don’t Expect A Rally
- The Insiders Are Selling Movado Group, But You Shouldn’t
- Beware The Rebound In Retail Stocks
- It’s A Good Time To Own Ralph Lauren (NYSE: RL)
- Block, Inc: Correcting for Negative Earnings
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.